International Clinical Trial: Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07807488) titled 'Bioequivalence Study of Rivaroxaban 2.5 mg Tablets Under Fasting and Fed Conditions' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: The Affiliated Hospital of Qingdao University

Condition: Healthy Participants

Intervention: Drug: Rivaroxaban 2.5 mg Test Tablet

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 16, 2022

Target Sample Size: 64

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT078...